|
Market Closed -
Euronext Paris
03:55:00 14/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.7210 EUR | -1.23% |
|
-3.61% | -24.90% |
| 10/11 | Transgene confirms financial visibility through 2028 |  |
| 10/11 | Weekly earnings agenda: SoftBank, CoreWeave, Nebius… AI looking for reassurance | |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TRANSGENE | Bio Therapeutic Drugs | -1.23% | -3.61% | -24.90% | -44.96% | -70.93% | 218M |  |  | |
- Stock Market
- Stocks
- TNG Stock
- Charts Transgene
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
